Литература / References

Поставить закладку

Злокачественные новообразования в России в 2015 году (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М.: МНИОИ им. П.А. Герцена, 2017. 250 с. [Malignant tumors in Russia in 2015 (inci‑ dence and mortality). Ed. by A.D. Kaprin, V.V. Starinskiy, G.V. Petrova. Moscow: P.A. Herzen Moscow Oncology Research Insti‑ tute, 2017. 250 p. (In Russ.)].
Мерабишвили В.М. Выживаемость онкологических больных. СПб., 2011. С. 178, 261–4. [Merabishvili V.M. Survival of cancer patients. Saint Petersburg, 2011. Pp. 178, 261–4. (In Russ.)].
Семиглазов В.Ф., Нургазиев К.Ш., Арзуманов А.С. Опухоли молочной железы (лечение и профилактика). Алматы, 2001. [Semiglazov V.F., Nurgaziev K.Sh., Arzu‑ manov A.S. Breast tumors (prevention and treatment). Almaty, 2001. (In Russ.)].
Fields R.C., Jeffe D.B., Trinkaus K. et al. Surgical resection of the primary tumor is associated with increased long‑term survival in patients with stage IV breast cancer after controlling for site of metastasis. Ann Surg Oncol 2007;14(12):3345–51. DOI: 10.1245/s10434‑007‑9527‑0. PMID: 17687611.
Семиглазов В.Ф., Моисеенко В.М. Со‑ временное лекарственное лечение местно‑ распространенного и метастатического рака молочной железы. СПб., 1997. С. 26–35. [Semiglazov V.F., Moiseenko V.M. Modern drug therapy for locally advanced and metastatic breast cancer. Saint Petersburg, 1997. Pp. 26–35. (In Russ.)].
Khan S.A. Does resection of an intact breast primary improve survival in metastatic breast cancer? Oncology (Williston Park) 2007;21(8):924–31. PMID: 17715695.
Sinha P., Clements V.K., Miller S., Ostrand‑ Rosenberg S. Tumor immunity: a balancing act between T cell activation, macrophage activa‑ tion and tumor‑induced immune suppression. Cancer Immunol Immunother 2005;54(11):1137–42. DOI: 10.1007/s00262‑005‑0703‑4. PMID: 15877228.
Wood W.C. Breast surgery in advanced breast cancer: local control in the presence of metas‑ tases. Breast 2007;16(Suppl 2):S63–6. DOI: 10.1016/j.breast.2007.07.008. PMID: 17889540.
Baum M., Demichelli R., Hrushesky W., Retsky M. Does surgery unfavourably perturb the “natural history” of early breast cancer by accelerating the appearance of distant metastases? Eur J Cancer 2005;41(4):508–15. DOI: 10.1016/j.ejca.2004.09.031. PMID: 15737554.
Coffey J.C., Wang J.H., Smith M.J. Excisional surgery for cancer cure: therapy at a cost. Lancet Oncol 2003;4(12):760–8. PMID: 14662433.
Fisher B., Grunduz N., Saffer E.A. Influ‑ ence of the interval between primary tumor re‑ moval and chemotherapy on kinetics and growth of metastases. Cancer Res 1983;43(4):1488–92. PMID: 6831397.
Grunduz N., Fisher B., Saffer E.A. Effect of surgical removal on the growth and kinetics of residual tumor. Cancer Res 1979;39(10):3861–5. PMID: 476622.
Kaufmann M., Henderson I.C., Egnofer E. Therapeutic management of metastatic breast cancer. Consensus Development in Cancer Therapy. Berlin; NY: de Gruyter, 1989. Pp. 67–8, 71, 77–8, 84.
Babiera G.V., Rao R., Feng L. et al. Effect of primary tumor extirpation in breast cancer patients who present with stage IV dis‑ ease and an intact primary tumor. Ann Surg Oncol 2006;13(6):776–82. PMID: 16614878.
Bafford A.C., Burstein H.J., Barkley C.R. et al. Breast surgery in stage IV breast cancer: Клинические рекомендации Российского общества онкомаммологов 201 8 impact of staging and patient selection on overall survival. Breast Cancer Res Treat 2009;115(1):7–12. DOI: 10.1007/s10549‑008‑0101‑7. PMID: 18581232.
Blanchard D.K., Shetty P.B., Hilsenbeck S.G., Elledge R.M. Association of surgery with improved survival in stage IV breast cancer patients. Ann Surg 2008;247(5):732–40. DOI: 10.1097/SLA.0b013e3181656d32. PMID: 18438108.
Cady B., Nathan N.R., Michaelson J.S. et al. Matched pair analyses of stage IV breast cancer with or without resection of primary breast site. Ann Surg Oncol 2008;15(12): 3384–95. DOI: 10.1245/s10434‑008‑0085‑x. PMID: 18726129.
Gnerlich J., Jeffe D.B., Deshpande A.D. et al. Surgical removal of the primary tumour increases overall survival in patients with meta‑ static breast cancer: analysis of the 1988–2003 SEER data. Ann Surg Oncol 2007;14(8):2187– 94. DOI: 10.1245/s10434‑007‑9438‑0. PMID: 17522944.
Lang J.E., Babiera G.V. Locoregional re‑ section in stage IV breast cancer: tumor biol‑ ogy, molecular and clinical perspectives. Surg Clin North Am 2007;87(2):527–38. DOI: 10.1016/j.suc.2007.01.001. PMID: 17498542.
Leung A.M., Vu H.N., Nguyen K.A. et al. Effects of surgical excision on survival of patients with stage IV breast cancer. J Surg Res 2010;161(1):83–8. DOI: 10.1016/j.jss.2008.12.030. PMID: 19375721.
Morrow M., Goldstein L. Surgery of the primary tumor in metastatic breast can‑ cer: closing the barn door after the horse has bolted? J Clin Oncol 2006;24(18):2694–6. DOI: 10.1200/JCO.2006.05.9824. PMID: 16702578.
Nash C.H. 3^rd, Jones S.E., Moon T.E. et al. Prediction of outcome in metastatic breast cancer treated with adriamycin combi‑ nation chemotherapy. Cancer 1980;46(11):2380–8. PMID: 6449280.
Rapiti E., Verkooijen H.M., Vlastos G. Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis. J Clin Oncol 2006;24(18):2743–9. PMID: 16702580.
Ruterkamp J., Voogd A.C., Bosscha K. et al. Impact of breast surgery on survival in pa‑ tients with distant metastases at initial presen‑ tation: a systematic review of the literature. Breast Cancer Res Treat 2010;120(1):9–16. DOI: 10.1007/s10549‑009‑0670‑0. PMID: 20012891.
Hortobagyi G.N., Smith T.L., Legha S.S. et al. Multivariate analysis of prognostic factors in metastatic breast cancer. J Clin Oncol 1983;1(12):776–86. PMID: 6668494.
Vincent M.D., Powles T.J., Skeet R. et al. An analysis of possible prognostic features of long term and short term survivors of meta‑ static breast cancer. Eur J Cancer Clin Oncol 1986;22(9):1059–65. PMID: 3780813.
Caras I., Grigorescu A., Stavaru C. et al. Evidence for immune defects in breast and lung cancer patients. Cancer Immunol Immu‑ nother 2004;53(12):1146–52. DOI: 10.1007/s00262‑004‑0556‑2. PMID: 15185014.
Campbell M.J., Scott J., Maecker H.T. al. Immune dysfunction and micrometasta‑ ses in women with breast cancer. Breast Cancer Res Treat 2005;91(2):163–71. DOI: 10.1007/s10549‑004‑7048‑0. PMID: 15868444.
Badwe R., Hawaldar R., Nair N. et al. Locoregional treatment versus no treatment of the primary tumour in metastatic breast can‑ cer: an open‑label randomized controlled trial. Lancet Oncol 2015;16(13):1380–8. DOI: 10.1016/S1470‑2045(15)00135‑7. PMID: 26363985.
Soran A., Ozmen V., Ozbas S. et al. A ran‑ domized controlled trial evaluating resection of the primary breast tumor in women present‑ ing with de novo stage IV breast cancer: Turkish Study (Protocol MF07‑01). J Clin Oncol 2016;34 Supl: abstr 1005.
Chia S.K., Speers C.H., D’yachkova Y. et al. The impact of new chemotherapeutic and hormone agents on survival in a popula‑ tion‑based cohort of women with metastatic breast cancer. Cancer 2007;110(5):973–9. DOI: 10.1002/cncr.22867. PMID: 17647245.
Comen E.A., Norton L., Massague J. Breast cancer tumour size, nodal status and prognosis: biology trumps anatomy. J Clin Oncol 2011;29(19):2610–2. DOI: 10.1200/JCO.2011.36.1873. PMID: 21606411.
Danna E.A., Sinha P., Gilbert M. et al. Surgical removal of primary tumor reverses tumor‑induced immunosuppression despite the presence of metastatic disease. Cancer Res 2004;64(6):2205–11. PMID: 15026364.
Khan S.A., Stewart A.K., Morrow M. Does aggressive local therapy improve survival in metastatic breast cancer? Surgery 2002;132(4):620–6. PMID: 12407345.
Harris E., Barry M., Kell M.R. Meta‑anal‑ ysis to determine if surgical resection of the pri‑ mary tumour in the setting of stage IV breast cancer impacts on survival. Ann Surg Oncol 2013;20(9):2828–34.DOI: 10.1245/s10434‑013‑2998‑2. PMID: 23653043.

Для продолжения работы требуется Регистрация

Предыдущая страница

Следующая страница